In 16 patients with NSCLC receiving docetaxel or docetaxel and carboplatin for advanced disease, CYP3A4 gene expression in peripheral mononuclear cells was analyzed. This evidence concerns the gene CYP3A4 and non-small cell lung carcinoma.